Optina Diagnostics

Visit Company

A simple eye scan to detect a key biomarker of Alzheimer’s disease. Optina Dx is developing a ground-breaking tool utilizing deep learning algorithms for identifying beta-amyloid (AB) plaques, a key biomarker of this disease.

David Lapointe, Founder and CEO of Optina Dx, talks about the technology within Optina Dx's eye scan for testing early detection of Alzeihmer's disease.

Company News:

September 05, 2018

DIAGNOS Partners with Optina Diagnostics, a Montreal Based Company, to Provide a Web Platform for the Early Detection of Alzheimer Disease. Read More